How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics?

@article{Cutroneo2004HowDG,
  title={How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics?},
  author={Kenneth R. Cutroneo and Kenneth M. Sterling},
  journal={Journal of Cellular Biochemistry},
  year={2004},
  volume={92}
}
This article demonstrates how glucocorticoids decrease collagen synthesis. The parameters used to assess procollagen synthesis in our laboratory will be compared to those used by others. This article will note all the pertinent literature on the molecular mechanisms of this down regulation of procollagen synthesis. For example, what are the effects of glucocorticoids at the levels of transcription and translation of collagen mRNAs? Finally, we will define a molecular mechanism to inhibit Type I… 
TGF‐β–induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring
  • K. Cutroneo
  • Biology, Chemistry
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
  • 2007
TLDR
The significance of the proposed studies is that these novel natural antifibrotics will mimic the effect of glucocorticoids on collagen synthesis during fibrogenesis without the unwanted side effects of these steroids.
Therapies for bleomycin induced lung fibrosis through regulation of TGF‐β1 induced collagen gene expression
TLDR
Lung fibroblasts exist as subpopulations with one subset predominately responding to fibrogenic stimuli which could be a specific cell therapeutic target for the onset and development of pulmonary fibrosis.
A novel nonsteroidal antifibrotic oligo decoy containing the TGF‐β element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis
TLDR
A double‐stranded oligodeoxynucleotide decoy injected into worm‐infected mice suppressed TGF‐β1, COL1A1, tissue inhibitor of metalloproteinase‐1, and decreased COL3A1 mRNAs to a lesser extent and has the potential to be employed as a novel antifibrotic treatment modality.
Anti-fibrotic effects of theophylline on lung fibroblasts.
Effect of corticosteroids and long-acting ß2- agonists in a human cell culture based "in vitro" model of airway inflammation and tissue remodeling
TLDR
Findings indicate that the effect of corticosteroids but not of LABA, on ECM deposition by fibroblasts is altered by ongoing inflammation, contributing to the progression and severity of diseases.
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
TLDR
The extracellular matrix (ECM) consists of numerous macromolecules classified traditionally into collagens, elastin, and microfibrillar proteins, proteoglycans including hyaluronan, and noncollagenous glycoproteins, and this activity may in part be beneficial to the drugs' disease-modifying properties.
Opposite effect of corticosteroids and long‐acting β2‐agonists on serum‐ and TGF‐β1‐induced extracellular matrix deposition by primary human lung fibroblasts
TLDR
The data suggest that the effect of corticosteroids, but not of LABA, on ECM deposition by fibroblasts is altered by serum, implying that as soon as airway inflammation is resolved, long‐term treatment with combined drugs may beneficially reduce pathological tissue remodeling.
Effect of the anti-inflammatory drugs Hostacortin ( steroidal ) or Vioxx ( non-steroidal ) on the liver of mice infected with Schistosom a mansoni .
TLDR
The treatment with Hostacortin was found to ameliorate to some extent the severity of the disease, but Vioxx treatment caused additional hepatotoxicity in the S. mansoni infected mice.
...
...

References

SHOWING 1-10 OF 57 REFERENCES
Glucocorticoids selectively decrease the synthesis of hydroxylated collagen peptides.
TLDR
Collagenase digestion of nascent polypeptide chains released from dermal polysomes demonstrated a selective, dose-dependent decrease in collagen polypePTide synthesis, indicating that glucocorticoids do not cause the synthesis and subsequent accumulation of underhydroxylated collagen.
Anti-inflammatory steroids and collagen metabolism: glucocorticoid-mediated alterations of prolyl hydroxylase activity and collagen synthesis.
TLDR
The data indicate that the general antianabolic effect of glucocorticoids on protein synthesis is succeeded by a specific effect on collagen synthesis, and suggest that the decrease of prolyl hydroxylase following treatment with glucoc Corticoids is involved in the molecular mechanism of action of this class of drugs on collagen biosynthesis.
Glucocorticoid and retinoid regulation of alpha‐2 type I procollagen promoter activity
TLDR
The results indicate that the single GRE and the RARE are required for glucocorticoid and retinoic acid regulation of proα2(I) collagen gene activity, respectively.
Anti‐inflammatory prednisolone derivatives inhibit collagen synthesis and pro‐α1 (I) collagen promoter activity in rat skin fibroblasts
  • K. Cutroneo, N. Meisler, D. F. Counts
  • Biology, Medicine
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
  • 1994
TLDR
The data suggest that metabolism, absorption, or distribution of these corticosteroids results in their inability to inhibit collagen synthesis in vivo, and fluorination in the 9α position of the adrenal steroid nucleus is not required for the inhibition of collagen synthesis by methyl‐20‐dihydroprednisolonate.
Glucocorticoid Regulation of Procollagen Synthesis
TLDR
These studies provide a molecular basis for the regulation of lung collagen content in experimental pulmonary fibrosis in animals and possibly in idiopathic pulmonary Fibrosis in humans and may provide a Molecular basis for dermal atrophy which results from topical application of glucocorticoids.
Relationship between glucocorticoid-mediated early decrease of protein synthesis and the steady state decreases of glucocorticoid receptor and TGF-beta activator protein.
  • K. Cutroneo
  • Biology, Medicine
    The international journal of biochemistry & cell biology
  • 2002
How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis
  • K. Cutroneo
  • Biology, Medicine
    Journal of cellular biochemistry
  • 2003
TLDR
This article will be primarily concerned with the response of injured tissues at the gene level of Type I procollagen synthesis in response to TGF‐β, and will focus on DNA binding sites on these two genes, which regulate the transcription of the specific gene.
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect
TLDR
The results indicate that systemic glucocorticoid treatment suppresses the synthesis of both type I and type III collagen in the dermis, and suggest that many side‐effects of these drugs, such as atrophy of the skin, are due to this inhibition.
Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid.
...
...